Are we seeing any breakthroughs in the treatment of AML?
Highlights from the International Symposium on Acute Leukemias (ISAL) 2017 in Munich
Progress in the development of treatments for leukemia
Highlights from EBMT 2016: Immunotherapy
Current research on CD19 targeted CAR T-cells in relapsed B-cell ALL